Lisa A. McGee, M.D.

Publications

  1. Manzar GS, Lester SC, Routman DM, Harmsen WS, Petersen MM, Sloan JA, Mundy DW, Hunzeker AE, Amundson AC, Anderson JL, Patel SH, Garces YI, Halyard MY, McGee LA, Neben-Wittich MA, Ma DJ, Frank SJ, Whitaker TJ, Foote RL. Comparative analysis of acute toxicities and patient reported outcomes between intensity-modulated proton therapy (IMPT) and volumetric modulated arc therapy (VMAT) for the treatment of oropharyngeal cancer. Radiother Oncol. 2020 Jun; 147:64-74 Epub 2020 Mar 29
    View PubMed
  2. Thorpe CS, Niska JR, Anderson JD, Girardo ME, McGee LA, Hartsell WF, Larson GL, Tsai HK, Rossi CJ, Rosen LR, Vargas CE. Acute toxicities after proton beam therapy following breast-conserving surgery for breast cancer: Multi-institutional prospective PCG registry analysis. Breast J. 2020 Apr 15 [Epub ahead of print]
    View PubMed
  3. Mutter RW, Jethwa KR, Gonuguntla K, Remmes NB, Whitaker TJ, Hieken TJ, Ruddy KJ, McGee LA, Corbin KS, Park SS. 3 fraction pencil-beam scanning proton accelerated partial breast irradiation: early provider and patient reported outcomes of a novel regimen. Radiat Oncol. 2019 Nov 21; 14 (1):211
    View PubMed
  4. Thorpe CS, Niska JR, Girardo ME, Kosiorek HE, McGee LA, Hartsell WF, Larson GL, Tsai HK, Rossi CJ, Rosen LR, Vargas CE. Proton beam therapy reirradiation for breast cancer: Multi-institutional prospective PCG registry analysis. Breast J. 2019 Nov; 25 (6):1160-1170 Epub 2019 July 23
    View PubMed
  5. Sio TT, Blanchard MJ, Novotny PJ, Patel SH, Rwigema JM, Pederson LD, McGee LA, Gamez ME, Seeger GR, Martenson JA, Grover Y, Neben Wittich MA, Garces YI, Foote RL, Miller RC, Halyard MY. N-Acetylcysteine Rinse for Thick Secretion and Mucositis of Head and Neck Chemoradiotherapy (Alliance MC13C2): A Double-Blind Randomized Clinical Trial. Mayo Clin Proc. 2019 Sep; 94 (9):1814-1824 Epub 2019 Aug 09
    View PubMed
  6. Evans JD, Harper Riley, Petersen Molly, Harmsen WS, Anand A, Hunzeker Ashley, Deiter Noelle, Schultz Heather, Jethwa KR, Lester SC, Routman D, Ma DJ, Garces YI, Neben-Wittich MA, Laack NN, Beltran C, Patel SH, McGee L, Rwigema J, Mundy DW, Foote RL. The Importance of Verification Computed Tomography Quality Assurance Scans in Patients Treated with Spot-Scanning Intensity Modulated Proton Therapy for Head and Neck Cancers IJROBP, June 2019. 2019.
  7. Zhu HJ, Nichols RC, Henderson RH, Morris CG, Flampouri S, Pham DC, Klassen CL, Seeram V, Cury JD, Jones L, McGee L, Hoppe BS. Impact of unfavorable factors on outcomes among inoperable stage II-IV Nonsmall cell lung cancer patients treated with proton therapy. Acta Oncol. 2019 Mar; 58 (3):313-319 Epub 2019 Jan 18
    View PubMed
  8. Gamez ME, Kraus R, Hinni ML, Moore EJ, Ma DJ, Ko SJ, Rwigema JCM, McGee LA, Halyard MY, Buras MR, Foote RL, Patel SH. Treatment outcomes of squamous cell carcinoma of the oral cavity in young adults. Oral Oncol. 2018 Dec; 87:43-48 Epub 2018 Oct 22
    View PubMed
  9. Thorpe CS, Niska JR, Brunnhoelzl DC, McGee LA, Kesslering CM, Hartsell WF, Vargas CE. First report of proton beam therapy for breast angiosarcoma from the prospective PCG registry. Acta Oncol 2018 Jul; 57 (7):992-994 Epub 2018 Jan 05
    View PubMed
  10. Gamez ME, Jeans E, Hinni ML, Moore E, Young G, Ma D, McGee L, Buras MR, Patel SH. Outcomes and patterns of failure of sarcomatoid carcinoma of the larynx: The Mayo Clinic experience. Laryngoscope. 2018 Feb; 128 (2):373-377 Epub 2017 July 06
    View PubMed
  11. Tseng YD, Cutter DJ, Plastaras JP, Parikh RR, Cahlon O, Chuong MD, Dedeckova K, Khan MK, Lin SY, McGee LA, Shen EY, Terezakis SA, Badiyan SN, Kirova YM, Hoppe RT, Mendenhall NP, Pankuch M, Flampouri S, Ricardi U, Hoppe BS. Evidence-based Review on the Use of Proton Therapy in Lymphoma From the Particle Therapy Cooperative Group (PTCOG) Lymphoma Subcommittee. Int J Radiat Oncol Biol Phys. 2017 Nov 15; 99 (4):825-842 Epub 2017 Sept 21
    View PubMed
  12. Hoppe BS, Hill-Kayser CE, Tseng YD, Flampouri S, Elmongy HM, Cahlon O, Mendenhall NP, Maity A, McGee LA, Plastaras JP. Consolidative proton therapy after chemotherapy for patients with Hodgkin lymphoma. Ann Oncol. 2017 Sep 1; 28 (9):2179-2184
    View PubMed
  13. Verma V, Iftekaruddin Z, Badar N, Hartsell W, Han-Chih Chang J, Gondi V, Pankuch M, Gao M, Schmidt S, Kaplan D, McGee L. Proton beam radiotherapy as part of comprehensive regional nodal irradiation for locally advanced breast cancer. Radiother Oncol. 2017 May; 123 (2):294-298 Epub 2017 Apr 27
    View PubMed
  14. Hoppe BS, Tsai H, Larson G, Laramore GE, Vargas C, Tseng YD, Dunn M, McGee L, Cahlon O, Hartsell W. Proton therapy patterns-of-care and early outcomes for Hodgkin lymphoma: results from the Proton Collaborative Group Registry. Acta Oncol. 2016 Nov; 55 (11):1378-1380 Epub 2016 Aug 31
    View PubMed
  15. McGee L, Mendenhall NP, Henderson RH, Morris CG, Nichols RC Jr, Marcus RJ Jr, Li Z, Mendenhall WM, Williams CR, Hoppe BS. Outcomes in men with large prostates (>/= 60 cm(3)) treated with definitive proton therapy for prostate cancer. Acta Oncol. 2013 Apr; 52 (3):470-6 Epub 2012 Dec 17
    View PubMed
  16. McGee L, Indelicato DJ, Dagan R, Morris CG, Knapik JA, Reith JD, Scarborough MT, Gibbs CP, Marcus RB Jr, Zlotecki RA. Long-term results following postoperative radiotherapy for soft tissue sarcomas of the extremity. Int J Radiat Oncol Biol Phys. 2012 Nov 15; 84: (4)1003-9.
    View PubMed
  17. Dagan R, Indelicato DJ, McGee L, Morris CG, Kirwan JM, Knapik J, Reith J, Scarborough MT, Gibbs CP, Marcus RB Jr, Zlotecki RA. The significance of a marginal excision after preoperative radiation therapy for soft tissue sarcoma of the extremity. Cancer. 2012 Jun 15; 118: (12)3199-207.
    View PubMed
PST-20258672